•
Mar 31, 2022

Albemarle Q1 2022 Earnings Report

Reported first quarter sales growth of 36% and raised guidance.

Key Takeaways

Albemarle Corporation announced strong first quarter results with net sales of $1.13 billion, a 36% increase year-over-year. The company raised its full year 2022 guidance due to increased prices in the Lithium and Bromine businesses.

Net sales of $1.13 billion, an increase of 36%.

Net income of $253.4 million, or $2.15 per diluted share; Adjusted diluted EPS of $2.38, an increase of 116%.

Adjusted EBITDA of $432 million, an increase of 88%.

2022 guidance revised upward on increased prices in Lithium and Bromine businesses.

Total Revenue
$1.13B
Previous year: $829M
+36.0%
EPS
$2.38
Previous year: $1.1
+116.4%
Adjusted EBITDA
$432M
Previous year: $230M
+87.7%
Gross Profit
$449M
Previous year: $264M
+70.3%
Cash and Equivalents
$463M
Previous year: $570M
-18.7%
Free Cash Flow
-$25.5M
Previous year: -$21.7M
+17.4%
Total Assets
$11.4B
Previous year: $10.3B
+10.9%

Albemarle

Albemarle

Forward Guidance

Albemarle’s outlook for 2022 has improved based on expectations of continued demand growth and tightness in the markets it serves. Net sales guidance was revised upward primarily due to continued strength in pricing in its Lithium and Bromine businesses. Adjusted EBITDA guidance is higher based on pricing expectations partially offset by inflationary cost pressures, particularly for natural gas in Europe.

Positive Outlook

  • Net sales are now expected to increase approximately 60-70% year-over-year.
  • Adjusted EBITDA is now expected to increase approximately 100-140% year-over-year.

Challenges Ahead

  • Inflationary cost pressures, particularly for natural gas in Europe, are expected to partially offset pricing expectations.